Wells Fargo & Company Dyne Therapeutics, Inc. Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 26,060 shares of DYN stock, worth $887,603. This represents 0.0% of its overall portfolio holdings.

Number of Shares

26,060

Previous 19,957 30.58%

Holding current value

$887,603

Previous $566,000 62.37%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$23.65 - $35.63 $144,335 - $217,449	6,103 Added 30.58%	26,060 $919,000
Q1 2024 May 10, 2024	BUY	$13.06 - $29.18 $90,479 - $202,159	6,928 Added 53.17%	19,957 $566,000
Q4 2023 Feb 09, 2024	SELL	$6.62 - $13.64 $147,076 - $303,039	-22,217 Reduced 63.03%	13,029 $173,000
Q3 2023 Nov 13, 2023	SELL	$8.6 - $12.18 $9,202 - $13,032	-1,070 Reduced 2.95%	35,246 $315,000
Q2 2023 Aug 15, 2023	BUY	$8.53 - $14.28 $259,900 - $435,097	30,469 Added 521.1%	36,316 $408,000
Q1 2023 May 12, 2023	BUY	$10.88 - $15.0 $63,615 - $87,705	5,847 New	5,847 $67,000
Q3 2022 Nov 14, 2022	SELL	$7.2 - $15.17 $2,268 - $4,778	-315 Reduced 88.48%	41 $1,000
Q2 2022 Aug 12, 2022	SELL	$4.36 - $10.5 $4,434 - $10,678	-1,017 Reduced 74.07%	356 $2,000
Q1 2022 May 16, 2022	SELL	$6.52 - $12.27 $69,581 - $130,945	-10,672 Reduced 88.6%	1,373 $13,000
Q4 2021 Feb 14, 2022	BUY	$11.89 - $16.07 $143,215 - $193,563	12,045 New	12,045 $144,000
Q3 2021 Nov 15, 2021	SELL	$15.6 - $21.46 $5,038 - $6,931	-323 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$15.94 - $22.33 $75,332 - $105,531	-4,726 Reduced 93.6%	323 $7,000
Q1 2021 May 13, 2021	SELL	$14.0 - $29.3 $32,760 - $68,562	-2,340 Reduced 31.67%	5,049 $78,000
Q4 2020 Feb 09, 2021	BUY	$16.81 - $23.94 $124,209 - $176,892	7,389 New	7,389 $155,000

Others Institutions Holding DYN

# of Institutions

201

Shares Held

106M

Call Options Held

82.7K

Put Options Held

24.8K

View Full List

About Dyne Therapeutics, Inc.

Ticker DYN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,765,400
Market Cap $1.76B
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...

More about DYN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Dyne Therapeutics, Inc. Transaction History